This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saitama, JP (2012)
- Tochigi, JP (2013)
Company Filing History:
Years Active: 2012-2013
Title: Innovations by Koichi Nakamaru in the Field of Inflammatory Bowel Disease
Introduction
Koichi Nakamaru is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory bowel diseases. With a total of 2 patents, Nakamaru's work focuses on developing novel therapeutic agents that address critical health issues.
Latest Patents
One of Nakamaru's latest patents is a therapeutic agent or prophylactic agent for inflammatory bowel disease, which comprises an amino alcohol derivative as the active ingredient. This innovative agent is represented by a specific general formula and acts as a sphingosine-1-phosphate receptor agonist. It offers a promising solution for patients suffering from inflammatory bowel diseases.
Another significant patent involves a method for treating inflammatory bowel disease using a specific 2-amino-1,3-propanediol derivative. This agent is particularly useful in treating conditions such as Crohn's disease, ulcerative colitis, and other related ailments. The therapeutic potential of these inventions highlights Nakamaru's commitment to advancing medical science.
Career Highlights
Koichi Nakamaru is associated with Kyorin Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a focus on developing effective treatments for complex health conditions, showcasing his expertise and dedication to improving patient outcomes.
Collaborations
Nakamaru has collaborated with notable colleagues, including Tokutarou Yasue and Naoya Yamamuro. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.
Conclusion
Koichi Nakamaru's contributions to the field of inflammatory bowel disease through his innovative patents demonstrate his significant impact on medical research and treatment. His work continues to inspire advancements in healthcare and offers hope for patients affected by these challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile